Vivus, Inc. – Patent Assignment Agreement (March 8th, 2017)
This Patent Assignment Agreement is entered into as of the Effective Date (as defined below), by and between Selten Pharma, Inc., a Cayman Islands company, having a principal place of business at 751 Laurel St, #520, San Carlos, CA 94070, ("SELTEN") and VIVUS, Inc., a Delaware company having a principal place of business at 900 E. Hamilton Ave., Suite 550, Campbell, California 95008 ("VIVUS").
Vivus, Inc. – Commercial Supply Agreement (November 9th, 2016)
THIS COMMERCIAL SUPPLY AGREEMENT (this "Agreement") is dated as of September 30, 2016, by and between VIVUS, Inc., a Delaware corporation with its principal place of business at 351 E. Evelyn Avenue, Mountain View, CA 94041 ("VIVUS"), and Metuchen Pharmaceuticals LLC, a limited liability company organized under the laws of Delaware, having its principal place of business at 11 Commerce Drive, 1st Floor, Cranford, New Jersey 07016 ("Purchaser"). VIVUS and Purchaser are sometimes referred to herein individually as a "Party" and collectively as the "Parties."
Vivus, Inc. – License and Commercialization Agreement (November 9th, 2016)
*** INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
Vivus, Inc. – Svai S. Sanford (November 4th, 2015)
Vivus, Inc. – AMENDMENT NO. 5 TO THE AMENDED AND RESTATED BYLAWS OF VIVUS, INC. September 15, 2015 (September 18th, 2015)
The Amended and Restated Bylaws of VIVUS, Inc., a Delaware corporation (the Company), initially adopted by the Board of Directors of the Company on May 16, 1996, as amended and restated on April 18, 2012 and as amended by Amendment No. 1 on February 20, 2013, Amendment No. 2 on April 26, 2013, Amendment No. 3 on May 9, 2013 and Amendment No. 4 on July 18, 2013 (the Bylaws), are hereby amended by this Amendment No. 5 (this Amendment) pursuant to Article IX thereof as set forth below.
Vivus, Inc. – LICENSE AND COMMERCIALIZATION AGREEMENT Dated as of October 10, 2013 by and Between VIVUS, INC. And AUXILIUM PHARMACEUTICALS, INC. (November 7th, 2013)
THIS LICENSE AND COMMERCIALIZATION AGREEMENT (the Agreement) is entered into as of the 10th day of October 2013 (the Effective Date) by and between VIVUS, INC., a Delaware corporation having its principal offices at 351 E. Evelyn Ave., Mountain View, CA 94041 (VIVUS), and AUXILIUM PHARMACEUTICALS, INC., a Delaware corporation having a place of business at 640 Lee Road, Chesterbrook, PA 19087. (Auxilium). VIVUS and Auxilium are sometimes referred to herein individually as a Party and collectively as the Parties.
Vivus, Inc. – November 4, 2013 Timothy E. Morris C/O VIVUS, Inc. (November 5th, 2013)
Vivus, Inc. – Employment Agreement (September 4th, 2013)
This EMPLOYMENT AGREEMENT (this Agreement ) is entered into as of September 3, 2013 (the Effective Date ) by and between VIVUS, Inc., a Delaware corporation (the Company ), and Seth H. Z. Fischer (Executive ).